BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28007141)

  • 1. Genetic and Pharmacological Inhibition of TREM-1 Limits the Development of Experimental Atherosclerosis.
    Joffre J; Potteaux S; Zeboudj L; Loyer X; Boufenzer A; Laurans L; Esposito B; Vandestienne M; de Jager SC; Hénique C; Zlatanova I; Taleb S; Bruneval P; Tedgui A; Mallat Z; Gibot S; Ait-Oufella H
    J Am Coll Cardiol; 2016 Dec; 68(25):2776-2793. PubMed ID: 28007141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing Triggering Receptors Expressed on Myeloid Cells-1 Impaired the Inflammatory Response to Oxidized Low-Density Lipoprotein in Macrophages.
    Li H; Hong F; Pan S; Lei L; Yan F
    Inflammation; 2016 Feb; 39(1):199-208. PubMed ID: 26277357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice.
    Akhtar S; Gremse F; Kiessling F; Weber C; Schober A
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):679-86. PubMed ID: 23393393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vav Guanine nucleotide exchange factors regulate atherosclerotic lesion development in mice.
    Rahaman SO; Li W; Silverstein RL
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2053-7. PubMed ID: 23825362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis.
    Fukuda D; Nishimoto S; Aini K; Tanaka A; Nishiguchi T; Kim-Kaneyama JR; Lei XF; Masuda K; Naruto T; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Kusunose K; Yamada H; Soeki T; Imoto I; Akasaka T; Shimabukuro M; Sata M
    J Am Heart Assoc; 2019 Apr; 8(7):e010860. PubMed ID: 30905257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
    Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.
    Xu XH; Shah PK; Faure E; Equils O; Thomas L; Fishbein MC; Luthringer D; Xu XP; Rajavashisth TB; Yano J; Kaul S; Arditi M
    Circulation; 2001 Dec; 104(25):3103-8. PubMed ID: 11748108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model.
    Nahon JE; Hoekstra M; Havik SR; Van Santbrink PJ; Dallinga-Thie GM; Kuivenhoven JA; Geerling JJ; Van Eck M
    Atherosclerosis; 2018 Jul; 274():120-127. PubMed ID: 29772480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses.
    Herías V; Biessen EA; Beckers C; Delsing D; Liao M; Daemen MJ; Pham CC; Heeneman S
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):79-86. PubMed ID: 25395616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic Cells Expressing Triggering Receptor Expressed on Myeloid Cells-1 Correlate with Plaque Stability in Symptomatic and Asymptomatic Patients with Carotid Stenosis.
    Rai V; Rao VH; Shao Z; Agrawal DK
    PLoS One; 2016; 11(5):e0154802. PubMed ID: 27148736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12.
    Hamerman JA; Jarjoura JR; Humphrey MB; Nakamura MC; Seaman WE; Lanier LL
    J Immunol; 2006 Aug; 177(4):2051-5. PubMed ID: 16887962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation.
    Salagianni M; Galani IE; Lundberg AM; Davos CH; Varela A; Gavriil A; Lyytikäinen LP; Lehtimäki T; Sigala F; Folkersen L; Gorgoulis V; Lenglet S; Montecucco F; Mach F; Hedin U; Hansson GK; Monaco C; Andreakos E
    Circulation; 2012 Aug; 126(8):952-62. PubMed ID: 22787112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
    Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
    Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis.
    Beneit N; Martín-Ventura JL; Rubio-Longás C; Escribano Ó; García-Gómez G; Fernández S; Sesti G; Hribal ML; Egido J; Gómez-Hernández A; Benito M
    Cardiovasc Diabetol; 2018 Feb; 17(1):31. PubMed ID: 29463262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD70 limits atherosclerosis and promotes macrophage function.
    Winkels H; Meiler S; Smeets E; Lievens D; Engel D; Spitz C; Bürger C; Rinne P; Beckers L; Dandl A; Reim S; Ahmadsei M; Van den Bossche J; Holdt LM; Megens RT; Schmitt M; de Winther M; Biessen EA; Borst J; Faussner A; Weber C; Lutgens E; Gerdes N
    Thromb Haemost; 2017 Jan; 117(1):164-175. PubMed ID: 27786334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR-2/TLR-4 TREM-1 signaling pathway is dispensable in inflammatory myeloid cells during sterile kidney injury.
    Campanholle G; Mittelsteadt K; Nakagawa S; Kobayashi A; Lin SL; Gharib SA; Heinecke JW; Hamerman JA; Altemeier WA; Duffield JS
    PLoS One; 2013; 8(7):e68640. PubMed ID: 23844229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREM-1 Mediates Inflammatory Injury and Cardiac Remodeling Following Myocardial Infarction.
    Boufenzer A; Lemarié J; Simon T; Derive M; Bouazza Y; Tran N; Maskali F; Groubatch F; Bonnin P; Bastien C; Bruneval P; Marie PY; Cohen R; Danchin N; Silvestre JS; Ait-Oufella H; Gibot S
    Circ Res; 2015 May; 116(11):1772-82. PubMed ID: 25840803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis.
    Zysset D; Weber B; Rihs S; Brasseit J; Freigang S; Riether C; Banz Y; Cerwenka A; Simillion C; Marques-Vidal P; Ochsenbein AF; Saurer L; Mueller C
    Nat Commun; 2016 Oct; 7():13151. PubMed ID: 27762264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Triggering Receptor Expressed on Myeloid cells-1: A new player during acute myocardial infarction.
    Jérémie L; Amir B; Marc D; Sébastien G
    Pharmacol Res; 2015 Oct; 100():261-5. PubMed ID: 26318764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.